Selective resonance of bodily agents

• US 8,195,403 B2
• Filed: 05/26/2006
• Issued: 06/05/2012
• Est. Priority Date: 07/21/2005
• Status: Active Grant

• Current Assignee: Enterprise Science Fund, LLC (Intellectual Ventures LLC)
• Original Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Jung, Edward K. Y., Leuthardt, Eric C., Myhrvold, Nathan P., Wood, Lowell L. Jr.
• Primary Examiner(s): Lin, Jerry
• Application Number:
  US11/441,786
• Publication Number:
  US 20070021458A1
• Time in Patent Office: 2,202 Days
• Field of Search: 702/19
• US Class Current: 702/19
• CPC Class Codes: A61K 31/4743 condensed with ring systems having sulfur as a ring hetero atom
• CPC Class Codes: A61K 41/0004 Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
• CPC Class Codes: A61N 1/306 Arrangements where at least part of the apparatus is introduced into the body
• CPC Class Codes: A61N 2/00 Magnetotherapy
• CPC Class Codes: C07K 1/00 General methods for the preparation of peptides , i.e. processes for the organic chemical preparation of peptides or proteins of any length
• CPC Class Codes: C07K 2299/00 Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Abstract

A chemical composition is introduced into the body and selectively or preferentially excited by the application of a score comprising a series of differing energy inputs that selectively resonate chemical structures of the composition.

Claims

1. A method, comprising:

introducing an agent into a body; and

directing a set of differing energy inputs towards the agent, wherein the set of differing energy inputs selectively resonates a plurality of resonant structures in the agent.

2. The method of claim 1, wherein the agent has a therapeutic effect in the body.

3. The method of claim 2, wherein directing the set of differing energy inputs towards the agent modulates the therapeutic effect in the body.

4. The method of claim 3, wherein directing the set of differing energy inputs towards the agent initiates the therapeutic effect in the body.

5. The method of claim 3, wherein directing the set of differing energy inputs towards the agent terminates the therapeutic effect in the body.

6. The method of claim 3, wherein modulating the therapeutic effect in the body comprises changing the character of the therapeutic effect in the body.

7. The method of claim 2, wherein directing the set of differing energy inputs towards the agent destroys the agent.

8. The method of claim 2, wherein the agent is selected from the group consisting of analgesics, antacids, antianxiety drugs, antiarrhythmics, anticoagulants, anticonvulsants, antidepressants, antidiarrheals, antiemetics, antifungals, antihistamines, antihypertensives, anti-inflammatories, antiplatelet drugs, antipsychotics, antipyretics, antivirals, barbiturates, beta-blockers, bronchodilators, chemotherapy drugs, corticosteroids, cough suppressants, cytotoxics, decongestants, diuretics, expectorants, hormones, hypoglycemics, immunosuppressives, laxatives, muscle relaxants, sedatives, sex hormones, sleeping drugs, tranquilizers, and vitamins.

9. The method of claim 8, wherein the agent is an antiplatelet drug.

10. The method of claim 9, wherein directing the set of differing energy inputs towards the agent destroys the agent.

11. The method of claim 10, wherein the agent is clopidogrel.

12. The method of claim 10, further comprising performing an incision on the body.

13. The method of claim 1, wherein the body is alive.

14. The method of claim 1, wherein the body is human.

15. The method of claim 1, wherein introducing the agent into the body comprises introducing the agent into the blood.

16. The method of claim 15, wherein directing the set of differing energy inputs towards the agent comprises directing the set of differing energy inputs into the body.

17. The method of claim 15, wherein directing the set of differing energy inputs towards the agent comprises directing the set of differing energy inputs into the blood external from the body, and further comprising introducing the blood into the body.

18. The method of claim 1, further comprising monitoring the body for activity of the agent.

19. The method of claim 1, further comprising monitoring the body for quantity of the agent.

20. The method of claim 1, wherein the agent comprises a functional group selected to be responsive to the set of differing energy inputs.

21. The method of claim 1, further comprising modifying the agent to add a functional group selected to be responsive to the set of differing energy inputs.

22. The method of claim 21, wherein the agent is modified to add the functional group prior to introducing the agent into the body.